Literature DB >> 11859458

In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.

Fabio Mengoni1, Miriam Lichtner, Lucia Battinelli, Monica Marzi, Claudio Maria Mastroianni, Vincenzo Vullo, Gabriela Mazzanti.   

Abstract

Oleanolic acid is a triterpenoid which is quite common in nature in the form either of free acid or in triterpenoid saponin glycosides. This study describes the effect of oleanolic acid on the growth of human immunodeficiency virus-1 (HIV-1) in cultures of human peripheral mononuclear cells (PBMC) and of monocyte/macrophages (M/M). Its inhibitory activity was also evaluated on PBMC obtained from HIV-1 infected patients. Results obtained show that oleanolic acid inhibits the HIV-1 replication in all the cellular systems used (EC50 values: 22.7 microM, 24.6 microM and 57.4 microM for in vitro infected PBMC, naturally infected PBMC and M/M, respectively). As regards the mechanism of action, oleanolic acid inhibits in vitro the HIV-1 protease activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859458     DOI: 10.1055/s-2002-20256

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  16 in total

Review 1.  Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance.

Authors:  Tanya Biswas; Upendra N Dwivedi
Journal:  Protoplasma       Date:  2019-07-11       Impact factor: 3.356

2.  Biotransformation using Mucor rouxii for the production of oleanolic acid derivatives and their antimicrobial activity against oral pathogens.

Authors:  Clarissa S Capel; Ana C D de Souza; Tatiane C de Carvalho; João P B de Sousa; Sérgio R Ambrósio; Carlos H G Martins; Wilson R Cunha; Rosario H Galán; Niege A J C Furtado
Journal:  J Ind Microbiol Biotechnol       Date:  2011-01-13       Impact factor: 3.346

3.  Zinc Lactate and Sapindin Act Synergistically with Lactocin 160 Against Gardnerella vaginalis.

Authors:  Yevgeniy Turovskiy; Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2011-06-01       Impact factor: 4.609

Review 4.  Targeting nrf2-mediated gene transcription by triterpenoids and their derivatives.

Authors:  Agnieszka Loboda; Ewa Rojczyk-Golebiewska; Barbara Bednarczyk-Cwynar; Zaprutko Lucjusz; Alicja Jozkowicz; Jozef Dulak
Journal:  Biomol Ther (Seoul)       Date:  2012-11       Impact factor: 4.634

Review 5.  Antimicrobial activity of oleanolic and ursolic acids: an update.

Authors:  Jéssica A Jesus; João Henrique G Lago; Márcia D Laurenti; Eduardo S Yamamoto; Luiz Felipe D Passero
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

6.  Oleanolic acid induced autophagic cell death in hepatocellular carcinoma cells via PI3K/Akt/mTOR and ROS-dependent pathway.

Authors:  Yang Shi; Qingwei Song; Dianhe Hu; Xiaohu Zhuang; Shengcai Yu; Dacai Teng
Journal:  Korean J Physiol Pharmacol       Date:  2016-04-26       Impact factor: 2.016

7.  Oleanolic Acid Prevents Increase in Blood Pressure and Nephrotoxicity in Nitric Oxide Dependent Type of Hypertension in Rats.

Authors:  Sagar S Bachhav; Mukesh S Bhutada; Sachin P Patil; Kinjal S Sharma; Savita D Patil
Journal:  Pharmacognosy Res       Date:  2014 Oct-Dec

8.  Active Components from Cassia abbreviata Prevent HIV-1 Entry by Distinct Mechanisms of Action.

Authors:  Yue Zheng; Xian-Wen Yang; Dominique Schols; Mattia Mori; Bruno Botta; Andy Chevigné; Martin Mulinge; André Steinmetz; Jean-Claude Schmit; Carole Seguin-Devaux
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

9.  Saponin inhibits hepatitis C virus propagation by up-regulating suppressor of cytokine signaling 2.

Authors:  Jihye Lee; Seri Lim; Sang-Min Kang; Saehong Min; Kidong Son; Han Sol Lee; Eun Mee Park; Huong T T Ngo; Huong T L Tran; Yun-Sook Lim; Soon B Hwang
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

10.  Effects of Lipophilic Extract of Viscum album L. and Oleanolic Acid on Migratory Activity of NIH/3T3 Fibroblasts and on HaCat Keratinocytes.

Authors:  R Kuonen; U Weissenstein; K Urech; M Kunz; K Hostanska; M Estko; P Heusser; S Baumgartner
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.